A comprehensive seroepidemiologic study was conducted in two Red Cross regions (Los Angeles and Miami) to determine the prevalence of Trypanosoma cruzi antibodies in at-risk blood donors, to identify additional risk factors, and to assess the likelihood of transmitting T. cruzi by transfusion. At-risk and control donors were stratified by a broad risk question, tested for T. cruzi antibodies, and if confirmed as seropositive, enrolled in case-control and lookback investigations. A total of 299,398 donors were queried; 23,978 at-risk and 25,587 control donations were tested, and T. cruzi antibodies were confirmed in 34 donors (33 and 1, respectively). Seropositive donors shared one risk factor; birth/extensive time in a T. cruzi -endemic area. Lookback studies identified 11 recipients, all negative for T. cruzi antibodies. Screening strategies that use a question are unlikely to identify all seropositive donors. The lack of definitive data on the risk of transmission by transfusion indicates additional studies of donors and recipients are needed.
The protozoan parasite Trypanosoma cruzi, the etiologic disease is endemic [4] , and 50,000 -100,000 of these immigrants may harbor chronic T. cruzi infections [5] . These inagent of Chagas' disease, is endemic in portions of Mexico, Central America, and South America, where it is estimated to fected persons represent a largely ''silent'' reservoir of T. cruzi, posing a risk of infecting recipients of blood donated by them. infect 16 -18 million people [1, 2] . Humans usually acquire the infection when feces from a hematophagous triatomine Indeed, 4 acute cases of T. cruzi infection acquired in the United States and Canada through blood transfusion have been insect (reduviid bug) infected with T. cruzi contaminate the conjunctivas, the oral or nasal mucosae, or the bite wound described, 3 of which involved T. cruzi -infected donors from T. cruzi -endemic areas in Latin America [6 -9] . Additionally, produced by the feeding insect. After an initial, generally mild acute phase, most infected persons enter a lifelong, asymptomthese 4 cases occurred in immunocompromised patients, and thus it is likely that additional cases have occurred in immunoatic indeterminate phase characterized by low-grade parasitemias and easily detectible antibodies to T. cruzi. Years or competent persons but were not recognized as Chagas' disease [3] . The extent to which public health, and in particular blood decades later, however, up to 30% of chronically infected persons develop symptomatic Chagas' disease, manifested by carcomponent safety, is threatened in the United States by T. cruzi -infected blood donors remains unclear. Estimates of diac and gastrointestinal dysfunction that results in Ç50,000 deaths per year [3] .
the seroprevalence of T. cruzi in the United States vary widely (0.06% -4.9%) [5, 10 -12] . A related study estimated that 1 in During the past several decades, several million persons have emigrated to the United States from countries in which Chagas' 340 blood donors in California has at least one reported risk factor for T. cruzi infection, but this study did not include antibody testing [13] . All these studies were designed primarily to determine seroprevalence or risk of T. cruzi infection in selected populations of blood donors, but they did not address Laboratory testing. Serum or plasma samples were tested for seropositive for T. cruzi. For all blood components from previous donations, records were tracked to determine the final disposition antibodies to T. cruzi (Chagas Antibody Enzyme Immunoassay Generation 2.0; Abbott Laboratories, Abbott Park, IL) as described of each component. Recipients of transfused components were identified by the transfusing facility and contacted by their primary in the manufacturer's product insert. If a sample was reactive initially, it was retested in duplicate and considered repeat-reactive physician or by letter to obtain blood samples for T. cruzi antibody testing and information about their clinical status. Serum or plasma if one or both of the two repeat tests were reactive. Samples that were initially nonreactive or those for which both of the repeat tests samples from recipients were tested by EIA and RIPA or alternative tests when access to samples was not permitted. were nonreactive were considered nonreactive. All EIA testing was done at the Southern California Region's research laboratories in Statistical analyses. Case-control data were analyzed by univariate analysis (Epi Info, version 6.03; CDC, Atlanta). For each Los Angeles.
All samples identified as repeat-reactive by EIA underwent conrisk factor univariate crude odds ratios (ORs) and 95% confidence intervals (CIs) were determined. Additional statistical analyses firmatory testing at the ARC's Holland Laboratory (Rockville, MD) using a radioimmunoprecipitation assay (RIPA) [14] . These were performed when appropriate using analysis of variance and x 2 analysis. P õ .05 was considered significant in all cases. samples were assayed in parallel with 3 negative and 3 positive control sera, the latter obtained from parasitologically confirmed cases of Chagas' disease. Diagnostic confirmation of seropositivity
Results

by RIPA was defined as the presence of bands in autoradiographs
Prevalence of antibodies to T. cruzi. During the 14-indicative of antibodies specific for the 72-and 90-kDa glycoproteins of T. cruzi. Any specimen that was EIA repeat-reactive and month study period, 299,397 blood donors were queried RIPA. Among samples from donors with a ''yes'' response, the rates of EIA repeat reactivity and RIPA-confirmed seroposiOf the 49,465 donations tested by EIA, 34 were confirmed as seropositive by RIPA, 33 (0.14%) from 23,978 ''yes'' tivity were not significantly different (x 2 Å 1.7, P Å NS and x 2 Å 0.4, P Å NS, respectively) in Los Angeles (0.32% and respondents and 1 (0.004%) from 25,478 ''no'' respondents (table 1) . It was subsequently learned, through a case-control 0.15%, respectively) compared with rates in Miami (0.19% and 0.09%, respectively). On the basis of the assumption that there interview, that this latter donor had answered the risk question in the negative, despite the fact that she was born and were no seropositive persons among the untested donors, the estimated rates of confirmed seropositivity
The rate of false-positive EIAs, defined as an EIA repeatof a lower proportion of ''yes'' respondents in Los Angeles.
Case-control studies. Of the 34 donors confirmed as seroposireactive test that was negative on RIPA testing, was comparable for ''yes'' and ''no'' respondents (0.16% and 0.13%, respective for T. cruzi, 26 participated in the case-control study. The [5] . A survey in Califorcontrast, index and control cases showed significant differences nia reported that 2.4% of blood donors had lived in T. cruzifor mean time spent in an endemic region, 20.6 years and 7. 4 endemic areas for more than a year [13] . Along the same lines, years, respectively. Furthermore, with one exception, all index we conducted a survey of 3000 randomly selected blood donors cases identified were born in countries where T. cruzi is endemic in six ARC US collection regions, using our stratification ques-(tables 2, 3). The exception was a 17-year-old woman born in tion, and found that 42 (2.5%) of the 1688 donors who particiLos Angeles to parents who had been born and had resided in El pated responded ''yes'' to the broad risk question (unpublished Salvador for many years (mother) and in T. cruzi-endemic areas data). On the basis of this survey and the present seroprevalence of Mexico (father). This donor had traveled to each of these areas, study, we estimate that at least 2.5% of blood donors nationand thus she may have acquired T. cruzi from an infected insect wide have geographic risk of exposure to T. cruzi, with higher or, less likely, via congenital transmission. On the basis of birth rates in certain areas, such as Miami and Los Angeles. Thus, and time spent in T. cruzi-endemic areas, the observation that it may be inferred that blood donors seropositive for T. cruzi our index cases identified themselves as Hispanic or of Spanishare not restricted to a limited number of US metropolitan areas speaking origin was expected. Last, the index cases showed a but can be found throughout the country. strong tendency toward lower socioeconomic levels than controls, A key issue is the extent to which the existence of T. cruzi specifically for measures of education level, family income, and infection among US blood donors impacts the health of the transhaving lived in simple housing (e.g., mud walls, unmilled logs fused population. This study showed no evidence of transmission and sticks, thatched roof) (table 2) . This final characteristic is to 11 recipients of blood from seropositive donors. However, the generally thought to be a risk factor for T. cruzi infection [4] , and upper 95% CI of this observation does not exclude the possibility 72% of our seropositive donors had lived in such houses.
of a 28% infectivity rate, a figure that is compatible with the Lookback investigations. Lookback investigations were car-13%-49% rates reported from South America [19] [20] [21] [22] [23] . Still, ried out for all 9 confirmed seropositive donors who had prethe absence of observed transmission is intriguing because the 4 viously donated blood. The dispositions of 69 components predocumented transfusion cases in the United States and Canada pared for transfusion are presented in figure 1 . Of the 14 recipients established that this route of transmission does occur in areas that who could be contacted, 3 declined to be tested, 1 was reportedly are not T. cruzi-endemic and includes cases involving donors tested by an immunofluorescence assay at the discretion of the who left T.cruzi-endemic areas 15-20 years earlier, as is well recipient's physician, and the remaining 10 recipients were tested known in T. cruzi-endemic countries. Parasites were present in the blood of seropositive persons, including 5 of 10 seropositive using EIAs (8 by ARC with Abbott EIA and 2 by others with / 9d35$$oc28 08-22-97 16:59:49 jinfal UC: J Infect Central American immigrants identified by Kirchhoff et al. [5] in quently maintained under conditions that favor parasite survival (22-24ЊC, shelf life of 5 days, enriched plasma environment). Washington, DC.
Because transmission by transfusion is likely to occur in the Recipients of platelets, moreover, are often immunocompromised [24, 25] and therefore may be more likely to have easily recognizUnited States, other factors may have contributed to our failure to observe transmission by transfusion. First, anticipated rates of able, fulminant courses of acute T. cruzi infection. The immune status of the tested recipients in our study was not determined. transmission by transfusion are based on published studies from South America that used different test procedures and algorithms As a caveat, platelet transfusion occurs less frequently in South America, but transmission by transfusion is common nonetheless, to define persons with T. cruzi infection. It is possible that we did not observe positive cases that would have been identified by perhaps due in part to the transfusion of whole blood in some regions [26] . alternative testing strategies (correctly or incorrectly), causing our rate to be comparatively low. Second, in the 4 North American Our lookback studies are continuing, and we hope to develop more precise estimates of transmission risk. In the meantime, our transfusion cases mentioned above, all recipients were transfused with at least one unit of platelets, while only 1 of our 11 lookback observations have important consequences for the development of intervention strategies. The concept of screening donors by quesrecipients received platelets ( figure 1 
